Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: A study of 77 cases

Department of Pathology, The Second Affiliated Hospital of Guangzhou Medical College, Guangzhou, China.
Modern Pathology (Impact Factor: 6.19). 10/2009; 22(12):1628-36. DOI: 10.1038/modpathol.2009.148
Source: PubMed


Primary germ cell tumors of the central nervous system (CNS) sometimes pose diagnostic difficulty. In this study we analyzed the diagnostic utility of a novel marker, SALL4, in 77 such tumors (59 pure and 18 mixed) consisting of the following tumors/tumor components: 49 germinomas, 7 embryonal carcinomas, 27 yolk sac tumors, 3 choriocarcinomas, and 14 teratomas. We also stained SALL4 in 99 primary non-germ cell tumors to test SALL4 specificity. We compared SALL4 with OCT4 in all germ cell tumors and compared SALL4 with alpha-fetoprotein and glypican-3 in all yolk sac tumors. The staining was semiquantitatively scored as 0 (no staining), 1+ (<or=30%), 2+(31-60%), 3+ (61-90%), and 4+ (>90%). Strong SALL4 staining was observed in all 49 germinomas (4+ in 48, 3+ in 1), 7 embryonal carcinomas (all 4+), and 27 yolk sac tumors (1+ in 1, 2+ in 2, 3+ in 7, 4+ in 17). SALL4 staining, 1+ weak to focally strong, was observed in 2 of 3 choriocarcinomas (in mononucleated trophoblasts) and in 9 of 14 teratomas (in primitive neuroepithelium and teratomatous glands). All germinomas and embryonal carcinomas showed strong OCT4 staining (4+ in all except 1 germinoma with 3+), whereas other germ cell tumors were negative. Out of 27 yolk sac tumors, 26 showed positive alpha-fetoprotein staining (1+ in 9, 2+ in 7, 3+ in 5, and 4+ in 5). All yolk sac tumors showed positive glypican-3 staining (1+ in 6, 2+ in 6, 3+ in 7, and 4+ in 8). The mean percentage of yolk sac tumor cells stained was 84% with SALL4, 45% with alpha-fetoprotein, and 63% with glypican-3 (P<0.01). No non-germ cell tumors showed SALL4 staining. Our results indicate that SALL4 is a novel sensitive diagnostic marker for primary germ cell tumors of the CNS with high specificity. SALL4 is a more sensitive marker than alpha-fetoprotein and glypican-3 for yolk sac tumors.

Download full-text


Available from: Maria M Rodríguez, Mar 27, 2014
  • Source
    • "At the meaning time, some other kinds of tumor such as colorectal cancer, breast cancer, and Wilms tumors also express SALL4 [4] [7] [8]. More recently, SALL4 has been suggested as a marker of germ cell tumor, including primary and metastatic of yolk sac tumor [9] [10] [11] [12] [13]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Aim: Sal-like protein 4 (SALL4), is reexpressed in tissues of a subgroup of HCC associated with poor prognosis. Reports of SALL4 serological levels linked to HCC patients are meager and unclear in the prognosis of this malignancy. Methods: Immunohistochemistry and optical microscopy protocols were used to examine the presence of SALL4 in liver tissues from the following patients: 38 HCC, 11 chronic hepatitis B virus (HBV), 13 liver cirrhosis, and 12 healthy controls. Additionally, enzyme-linked immunosorbent assay (ELISA) was used to measure the SALL4 levels in serum samples isolated from patients as follows: 127 with HCC, 27 with HBV, 24 with liver cirrhosis, and 23 normal controls. Results: Analysis of liver tissues sections from HCC patients (18 out 38; 47.4%) showed positive staining for SALL4 and its expression did no correlate with any of the clinicopathologic characteristics. HCC patients displayed higher levels (50.4%) of SALL4 protein in serum, compared with the three control groups. Moreover, SALL4 concentration reached the maximum level after one week after treatment and dropped quickly after one month. These HCC patients showing high SALL4 serum levels had poor prognosis, evidenced by both tumor recurrence and overall survival rate. Conclusions: High SALL4 serum levels are a novel biomarker in the prognosis of HCC patients.
    Full-text · Article · Apr 2014 · Research Journal of Immunology
  • Source
    • "The typical morphologic structures of endodermal sinus pattern known as sinuses of Duval, Schiller-Duval bodies, or glomerulus-like structures, superficially resemble immature renal glomeruli [7]. The three sensitive diagnostic markers for yolk sac tumor are alpha-fetoprotein, glypican-3 and SALL4 [3,7]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Yolk sac tumor (endodermal sinus tumor) is a rare malignant germ cell tumor arising in the testis or ovary. Extragonadal yolk sac tumor is even rarer and has only been described in case reports. Due to the rarity of the tumors, the appropriately optimal treatment remains unclear. We report a case of yolk sac tumor in the seminal vesicle. Case A 38-year-old Asian male presented with gross hematuria and hemospermia. Transrectal ultrasound scan showed a solid mass in the left seminal vesicle and the scrotal sonography showed no abnormalities. Bilateral seminal vesicles were resected, and histopathological examination showed a typical pattern of yolk sac tumor (YST). The patient responded poorly to comprehensive treatment of radiotherapy, chemotherapy and surgeries, developed systemic multiple metastases, and died of cachexia one and half years after diagnosis.
    Full-text · Article · Sep 2012 · World Journal of Surgical Oncology
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper presents the design of synchronous and asynchronous architectures for a Discrete Fourier Transform (DFT) based Finite Impulse Response (FIR) filter. The one dimensional filter is based on the delayed Least Mean Squares (DLMS) algorithm. The architecture is derived for a 1 × 4 array of processing elements. The proposed synchronous architecture is applied in adaptive equalization and the convergence results are analyzed using Matlab. The functionality of the architecture is verified by simulation via Actel's Veribest VHDL simulator. The synchronous architecture is modified to operate in asynchronous mode by implementing a two phase handshaking protocol between the processing elements (PEs). The performance of the proposed architectures is analyzed in terms of speed up, adaptation delay and throughput. The proposed DFT based DLMS systolic architecture leads to faster convergence when compared to conventional DLMS systolic architecture. In the asynchronous architecture the processors are clock independent. This reduces the adaptation delay and increases the throughput. The architectures are highly modular and very much suitable for VLSI implementation.
    No preview · Conference Paper · Apr 2004
Show more